Pharmafile Logo

Lucid Group becomes a sponsor of MedComms Networking

September 23, 2016 |  

- PMLiVE
To help Lucid access the valuable medical communications professional network they have become a sponsor of MedComms Networking, headed by Peter Llewellyn. Jan Steele (Co-founder and COO of Lucid Group) commented, “Our organisation has experienced rapid growth over the last 10 years. Attracting, developing and nurturing our talented people has been key to our success. However, over the last year, finding experienced medical writers has become particularly difficult. Becoming part of Peter’s professional network is a great opportunity to not only become more involved in the medical communications community as a whole, but also become more visible as an agency where talented medical writers seeking a better work–life balance want to be.” 

Earlier this month Lucid Group launched its recruitment campaign for attracting experienced world-class medical writers by offering them tailor-made employment packages. Daniel Newbury, Lucid’s Talent Acquisition Manager, explains: “We want to give experienced medical writers the opportunity to define the framework of their Lucid Life contract – from everyday experiences, to career progression and job flexibility. We are the only healthcare agency to offer employees bespoke packages that are designed for them alone.” 

If you want to know more about Lucid or are interested in scoping out your Lucid Life contract, visit www.lucid-group.co.uk or contact Dan (daniel@lucid-group.co.uk; 01494 755 495).

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Cultivating a learner-led culture: agile learning and the growth mindset

In this month’s Smart Thinking blog on PM.Live.com, Michelle Sweet, Learning and Development Consultant at Lucid Group, discusses the needs for a learner-led culture and a growth mindset in the...

Bluedog expands into the US with the appointment of George Pearson as Client Solutions Director

Bluedog, a Lucid Group Company, has elevated and expanded its creative team into the US with the appointment of George Pearson as Client Solutions Director.George is a highly experienced medical...

The inescapable rise of patient-centricity

The April issue of PME questions the meaning of ‘patient-centricity’ and whether we are achieving it.Patient-centricity has become a ubiquitous value within the pharmaceutical industry; however, is pharma delivering on...

Vivid welcomes magical new talent to the team

Vivid Medical Communications, a Lucid Group company, is delighted to announce two magical additions to the team.Deborah Blain joins Vivid as an Account Manager. With over 10 years’ experience in...

Easter Magic for Lucid Group

Lucid’s Futures Executives were set the challenge of planning a magical Easter surprise across its seven offices. After an egg-citing (sorry!) brainstorm the grads chose three activities.-    Egg-cellent Easter egg hunt-    You’re...

Lucid Group announces the appointment of new CFO

Lucid Group continues to build its infrastructure in line with its ambitious growth plans by appointing Michael Joyce as Chief Financial Officer (CFO).Michael has considerable experience as a CFO and...

Lucid Group Launch a Pioneering Leadership Programme for its Business Leaders

Great companies start with great leaders. However effective leadership requires skill, emotional intelligence, and most importantly, on-going self-improvement.With this in mind, Lucid Group has launched a new leadership programme for...

Leading Edge, a Lucid Group company, strengthens its senior client services team

Leading Edge, a Lucid Group company, is delighted to announce the appointment of its new Lead Client Partnership Director, Frances O’Connor.Frances is an experienced strategic healthcare communicator with expertise in...

From Cowgirl to Medical Writer – How did that happen?

Amy Jackson, Editorial Director, Lucid Group discusses her unlikely path into Medical Communications.

Measures for measures

Why pharma’s marketing metrics must close the loop